- Home
- CLEU vs XCUR Comparison
CLEU vs XCUR Comparison
Compare CLEU & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLEU
- XCUR
- Stock Information
- Founded
- CLEU 2011
- XCUR 2011
- Country
- CLEU China
- XCUR United States
- Employees
- CLEU N/A
- XCUR N/A
- Industry
- CLEU Other Consumer Services
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- CLEU Real Estate
- XCUR Health Care
- Exchange
- CLEU Nasdaq
- XCUR Nasdaq
- Market Cap
- CLEU 6.4M
- XCUR 6.9M
- IPO Year
- CLEU 2020
- XCUR N/A
- Fundamental
- Price
- CLEU $0.21
- XCUR $2.90
- Analyst Decision
- CLEU
- XCUR
- Analyst Count
- CLEU 0
- XCUR 0
- Target Price
- CLEU N/A
- XCUR N/A
- AVG Volume (30 Days)
- CLEU 182.3K
- XCUR 50.6K
- Earning Date
- CLEU 11-26-2024
- XCUR 11-14-2024
- Dividend Yield
- CLEU N/A
- XCUR N/A
- EPS Growth
- CLEU N/A
- XCUR N/A
- EPS
- CLEU N/A
- XCUR N/A
- Revenue
- CLEU $2,413,409.00
- XCUR $500,000.00
- Revenue This Year
- CLEU N/A
- XCUR N/A
- Revenue Next Year
- CLEU N/A
- XCUR N/A
- P/E Ratio
- CLEU N/A
- XCUR N/A
- Revenue Growth
- CLEU N/A
- XCUR N/A
- 52 Week Low
- CLEU $0.20
- XCUR $1.44
- 52 Week High
- CLEU $4.74
- XCUR $6.00
- Technical
- Relative Strength Index (RSI)
- CLEU 29.56
- XCUR 51.84
- Support Level
- CLEU $0.23
- XCUR $2.62
- Resistance Level
- CLEU $0.24
- XCUR $3.54
- Average True Range (ATR)
- CLEU 0.02
- XCUR 0.46
- MACD
- CLEU -0.00
- XCUR 0.03
- Stochastic Oscillator
- CLEU 9.62
- XCUR 41.98
About CLEU China Liberal Education Holdings Limited
China Liberal Education Holdings Ltd is an educational service provider operating in China. The company's operating segment includes Sino-foreign Jointly Managed Academic Programs, textbooks and course material sales, Overseas Study Consulting Services, Technological Consulting Services for Smart Campus Solutions and Tailored Job Readiness Training Services. Geographically, it derives revenue from China.
About XCUR Exicure Inc.
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.